SODIUM ACETATE INJECTION, USP
FRESENIUS KABI CANADA LTD
Quick answers
Is there a shortage of SODIUM ACETATE INJECTION, USP in Canada?
No. There is no current shortage of SODIUM ACETATE INJECTION, USP 328MG reported to Health Canada. Stock can still vary from one pharmacy to another.
⚠ Possible Recall or Safety Alert
Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.
Sodium Acetate Injection USP
Sodium Acetate Injection USP; Incorrect GTIN
Moderate health risk
Possible match — not confirmed
Sodium Acetate Injection, USP
Sodium Acetate Injection, USP - Potential for the Presence of Particulate Matter
Possible match — not confirmed
Sodium Acetate Injection, USP
Sodium Acetate Injection, USP: Particulate matter
Highest health risk
Possible match — not confirmed
DIN
02139529
Strength
328MG
Dosage Form
Solution
Route
Intravenous
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from FRESENIUS KABI CANADA LTD
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
900MG · DIN 02395150
20MG · DIN 02538644
50MG · DIN 02403536
50MG · DIN 02236926
DIN 02497697
3MG · DIN 02457482
3MG · DIN 02267659
3MG · DIN 02457474
50MG · DIN 02245248
250MG · DIN 02227029
2G · DIN 02226995
1G · DIN 02227002